Previous studies reported decreased frequency and function of anti-inflammatory and immunosuppressive CD4+CD25+FOXP3+ Tregs in blood of AD patients [52, 58] and experimental animal models [6]. This evidence concerns the gene CD4 and Alzheimer disease.